Browse All Needles & Syringe Products from MYCO Medical References: 1
Factors Requiring Dosage Modifications Several factors might need a change in B12 injection dosage
Patients are encouraged to maintain open communication with their GP, bariatric nurse, and dietitian, and to attend follow-up appointments consistently
Research is ongoing and the peptide doesnt have FDA approval
For patients who are deficient in B12 or borderline low, correcting that deficiency may help improve fatigue, sluggishness, or weakness
At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity